Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 13,538,000 | 14,886,000 | 14,342,000 | 13,959,000 | 13,010,000 |
| Cost of Goods | 4,052,000 | 4,320,000 | 4,390,000 | 4,523,000 | 4,213,000 |
| Gross Profit | 9,486,000 | 10,566,000 | 9,952,000 | 9,436,000 | 8,797,000 |
| Operating Expenses | 4,769,000 | 5,492,000 | 5,646,000 | 4,995,000 | 4,694,000 |
| Operating Income | 4,717,000 | 5,074,000 | 4,306,000 | 4,441,000 | 4,103,000 |
| Interest Expense | 539,000 | 571,000 | 585,000 | 606,000 | 622,000 |
| Other Income | 751,000 | -232,000 | -33,000 | -2,672,000 | 386,000 |
| Pre-tax Income | 4,929,000 | 4,271,000 | 3,688,000 | 1,163,000 | 3,867,000 |
| Income Tax | 436,000 | 226,000 | 508,000 | 394,000 | 312,000 |
| Net Income Continuous | 4,493,000 | 4,045,000 | 3,180,000 | 769,000 | 3,555,000 |
| Minority Interests | 3,000 | 1,000 | 1,000 | 3,000 | 2,000 |
| Net Income | $4,490,000 | $4,044,000 | $3,179,000 | $766,000 | $3,553,000 |
| EPS Basic Total Ops | 2.52 | 2.28 | 1.78 | 0.42 | 2.00 |
| EPS Basic Continuous Ops | 2.54 | 2.28 | 1.80 | 0.43 | 2.01 |
| EPS Diluted Total Ops | 2.51 | 2.26 | 1.78 | 0.42 | 1.99 |
| EPS Diluted Continuous Ops | 2.53 | 2.27 | 1.79 | 0.43 | 2.00 |
| EBITDA(a) | $6,770,000 | $7,053,000 | $6,433,000 | $6,641,000 | $6,318,000 |